Simira Unipath Diagnostics Private Limited, a active private limited company, was established on 03 January 2020 in Panvel, Maharashtra, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U85190MH2020PTC335458. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.15 M.
Employing 129 professional, Its leadership includes Jwalant Sureshbhai Shah (Director), Aruna Santosh Wakchaure (Director), Santosh Wakchaure (Director). Past directors included Jwalant Sureshbhai Shah, Supriya Ganesh Wakchaure, Ganesh Uttam Wakchaure. It holds ₹9.42 M open charges and ₹1.72 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 405, Bhoomi Landmark Chs, Plot No. 34/35A, Sector 17, Khanda Colony,, Panvel, Maharashtra, 410206.
U85190MH2020PTC335458
335458
03 January 2020
₹0.50 M
₹0.15 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Simira Unipath Diagnostics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jwalant Sureshbhai Shah | Director | 06 Jan 2024 | Current |
| Aruna Santosh Wakchaure | Director | 16 May 2023 | Current |
| Santosh Wakchaure | Director | 03 Jan 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Feb 2024 | Past |
| Pramod Abcsdd | Director | 06 Jan 2024 | Past |
| Pramod Abcsdd | Director | 06 Jan 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Simira Unipath Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 82.89% increase. The company also saw a substantial fall in profitability, with a 245.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 140.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Simira Unipath Diagnostics had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,424,460.00
₹17,179,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jun 2023 | Others | ₹5.00 M | Open |
| 25 Apr 2023 | Others | ₹2.62 M | Open |
| 22 Jun 2022 | Others | ₹1.80 M | Open |
| 06 Apr 2023 | Tjsb Sahakari Bank Limited | ₹1.78 M | Satisfied |
| 26 Aug 2022 | Tjsb Sahakari Bank Limited | ₹2.69 M | Satisfied |
Explore comprehensive loan charge details -
Simira Unipath Diagnostics has a workforce of 129 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Simira Unipath Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Simira Unipath Diagnostics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Simira Unipath Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
A charge registered on 06 Apr 2023 via Charge ID 100708190 with Tjsb Sahakari Bank Limited was fully satisfied on 22 Apr 2024. was recorded as a recent event.
Progress on A charge registered on 26 Aug 2022 via Charge ID 100604897 with Tjsb Sahakari Bank Limited was fully satisfied on 22 Apr 2024. was documented.
Progress on Simira Unipath Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on A charge registered on 30 Dec 2021 via Charge ID 100527119 with Tjsb Sahakari Bank Limited was fully satisfied on 10 Jan 2024. was documented.
The activity A charge registered on 20 Nov 2021 via Charge ID 100507509 with Tjsb Sahakari Bank Limited was fully satisfied on 10 Jan 2024. was completed.
The CIN of Simira Unipath Diagnostics Private Limited is U85190MH2020PTC335458.
Simira Unipath Diagnostics Private Limited is headquartered at Office No. 405, Bhoomi Landmark Chs, Plot No. 34/35A, Sector 17, Khanda Colony,, Panvel, Maharashtra, 410206.
Simira Unipath Diagnostics Private Limited was incorporated on 03 January 2020.
The current directors of Simira Unipath Diagnostics Private Limited are
The primary industry of Simira Unipath Diagnostics Private Limited is Hospital And Medical Care.
Simira Unipath Diagnostics Private Limited is unlisted.
The authorized capital of Simira Unipath Diagnostics Private Limited is ₹0.50 M, and the paid-up capital is ₹0.15 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX